Jiangxi Fushine Pharmaceutical Co., Ltd.

¥13.73As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300497Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.47%)
Div yield 0.73%
ROE 16.86%
Biotechnology
Beta (5Y) 0.35
PE TTM 18.76
TSR TTM 32.02%
Mkt cap ¥7.396B
ROIC 11.95%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
19.19%
(73.77%)
Sell 3|12|7|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.24
0.26
0.27
0.29
24.77%
17.92%
31.66%
31.11%
Revenue¥M
482.0
501.9
494.5
508.0
6.50%
7.70%
1.12%
5.12%
Peers (US$1.109B)
Cap (US$)
PE
1.124B
34.63x
Capital
TTM
5Y
10Y
Leveragex
5.676
0.910
0.702
EBIT/Intx
9.645
0.175
0.169
Own earn%
(9.44)
6.82
11.57
Sh yield%
30.96
6.26
7.80
Owners
Insiders/Inst%
14.27
85.71
Short interest%
0.76
SBC / revenue%
3.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
3